Form 4 for PRQR ProQR Therapeutics N.V.
Accepted 2026-08-03 16:01:11 ET · period of report 2026-07-31 · accession 0001104659-26-089780 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-03 16:01 | 2026-07-31 | PRQR | de Boer Daniel Anton | CEO, Dir | P - Purchase | $1.77 | +200.0K | 500.0K | +67% | +$354.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-07-31 | P | A | 200,000 | $1.77 | 500,000 | D | — | — |